Share

July 02, 2013; 81 (1) Article

Prospective study of restless legs syndrome and mortality among men

Yanping Li, Wei Wang, John W. Winkelman, Atul Malhotra, Jing Ma, Xiang Gao
First published June 12, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318297eee0
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
822

Share

Article Information

vol. 81 no. 1 52-59
DOI: 
https://doi.org/10.1212/WNL.0b013e318297eee0
PubMed: 
23761622
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received November 8, 2012
  • Accepted in final form March 8, 2013
  • First Published June 12, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Yanping Li, PhD,
    2. Wei Wang, MD, PhD,
    3. John W. Winkelman, MD, PhD,
    4. Atul Malhotra, MD,
    5. Jing Ma, MD, PhD and
    6. Xiang Gao, MD, PhD
  1. Yanping Li, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Wei Wang, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. John W. Winkelman, MD, PhD,
    4. Scientific Advisory Boards:

    1. Zeo Incorporated

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Sleep, Associate Editor, 2008- Sleep Medicine, Editorial Board 2004- CNS Drugs, Editorial Board 2004-

    Patents:

    1. NONE

    Publishing Royalties:

    1. Fundamentals of Psychiatric Sleep Medicine, 2010

    Employment, Commercial Entity:

    1. Brigham and Women's Hospital, physician

    Consultancies:

    1. 1) Impax Pharmaceuticals, 2) UCB Pharma

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) GlaxoSmithKline, 2) Impax Pharmaceuticals, 3) UCB Pharma

    Research Support, Government Entities:

    1. National Institute of Mental Health R01MH095792-01A1

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Axinn, Veltrop and Harkrider LLP, 2009-2012

  4. Atul Malhotra, MD,
    5. Scientific Advisory Boards:

    1. I have received consulting and/or research income from NIH, AHA, SGS, SHC, Pfizer, Philips, Apnex, Apnicure

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. editorial board of AJRCCM and Chest; associate editor at Sleep

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. I have received consulting and/or research income from NIH, AHA, SGS, SHC, Pfizer, Philips, Apnex, Apnicure

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. I have grant funding from NIH and AHA. I previously had research and/or consulting income from Philips, SHC, SGS, Apnex, Apnicure and Pfizer but none is relevant to the present manuscript. I have relinquished all outside personal income since May 2012

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. i have multiple nih grants but none related to this topic

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Jing Ma, MD, PhD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Xiang Gao, MD, PhD
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Has reported consultancy relationship with Teva

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From The Channing Laboratory (Y.L., J.M., X.G.) and the Division of Sleep Medicine (J.W.W., A.M.), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Department of Otolaryngology (W.W.), Tianjin First Central Hospital, Tianjin, China; and Department of Nutrition (W.W., X.G.), Harvard School of Public Health, Boston, MA.
  1. Correspondence to Dr. Gao: xgao{at}hsph.harvard.edu or Dr. Li: yanping.li{at}channing.harvard.edu
View Full Text

Article usage

Article usage: June 2013 to December 2022

AbstractFullPdfSource
Jun 20132865667Highwire
Jul 2013249932347Highwire
Aug 20135951225Highwire
Sep 2013363533Highwire
Oct 201325378Highwire
Nov 2013188814Highwire
Dec 201316135Highwire
Jan 201415739Highwire
Feb 201413655Highwire
Mar 201412325Highwire
Apr 201411024Highwire
May 201413887Highwire
Jun 20146643Highwire
Jul 20147220Highwire
Aug 20144910Highwire
Sep 20147001Highwire
Oct 20145822Highwire
Nov 20146142Highwire
Dec 20146212Highwire
Jan 20156731Highwire
Jan 2015093pmc
Feb 20154800Highwire
Feb 2015073pmc
Mar 20158633Highwire
Mar 20150125pmc
Apr 20154420Highwire
Apr 2015043pmc
May 20155313Highwire
May 20150123pmc
Jun 201510212Highwire
Jun 201501414pmc
Jul 20155721Highwire
Jul 20150126pmc
Aug 20158200Highwire
Aug 201502212pmc
Sep 20157810Highwire
Sep 20150125pmc
Oct 20153831Highwire
Oct 20150145pmc
Nov 20156302Highwire
Nov 20150117pmc
Dec 20155500Highwire
Dec 201501213pmc
Jan 20163410Highwire
Jan 20160147pmc
Feb 20163300Highwire
Feb 2016095pmc
Mar 20163521Highwire
Mar 2016042pmc
Apr 20163831Highwire
Apr 2016081pmc
May 20164000Highwire
May 2016084pmc
Jun 20164000Highwire
Jun 20160137pmc
Jul 20164400Highwire
Jul 2016084pmc
Aug 20167300Highwire
Aug 20160150pmc
Sep 20165100Highwire
Sep 20160135pmc
Oct 20165400Highwire
Oct 20160122pmc
Nov 201614300Highwire
Nov 20160147pmc
Dec 20164700Highwire
Dec 20160184pmc
Jan 20173811Highwire
Jan 20170103pmc
Feb 20173500Highwire
Feb 2017085pmc
Mar 20173000Highwire
Mar 2017072pmc
Apr 20173811Highwire
Apr 2017289pmc
May 20173300Highwire
May 201731313pmc
Jun 20173900Highwire
Jun 20174109pmc
Jul 20172900Highwire
Jul 201751821pmc
Aug 20172100Highwire
Aug 201741110pmc
Sep 20172100Highwire
Sep 20171106pmc
Oct 20173200Highwire
Oct 20172911pmc
Nov 20172501Highwire
Nov 2017079pmc
Dec 20173400Highwire
Jan 20183210Highwire
Feb 20183710Highwire
Mar 20185911Highwire
Apr 20183910Highwire
Apr 2018189pmc
May 20184710Highwire
Jun 20185001Highwire
Jun 2018065pmc
Jul 20184311Highwire
Aug 20182301Highwire
Aug 201831011pmc
Sep 20183000Highwire
Oct 20184200Highwire
Nov 20186800Highwire
Dec 20184600Highwire
Jan 20194100Highwire
Feb 20194900Highwire
Mar 20193100Highwire
Apr 20193700Highwire
May 20192800Highwire
Jun 20191600Highwire
Jul 20191300Highwire
Aug 20193100Highwire
Sep 20193800Highwire
Oct 20192912Highwire
Nov 20192511Highwire
Dec 20192300Highwire
Jan 20203200Highwire
Feb 20201601Highwire
Mar 20203210Highwire
Apr 20203500Highwire
May 20203810Highwire
Jun 20204610Highwire
Jul 20206200Highwire
Aug 20203200Highwire
Sep 20205200Highwire
Oct 202010200Highwire
Nov 20204341Highwire
Dec 20205600Highwire
Jan 20213200Highwire
Feb 20216410Highwire
Mar 20215400Highwire
Apr 20215210Highwire
May 20213000Highwire
Jun 20212500Highwire
Jul 20213000Highwire
Aug 20215110Highwire
Sep 20214400Highwire
Oct 20215411Highwire
Nov 20214401Highwire
Dec 20214901Highwire
Jan 20223601Highwire
Feb 20224000Highwire
Mar 20226400Highwire
Apr 20223200Highwire
May 20224700Highwire
Jun 20222000Highwire
Jul 20222901Highwire
Aug 20223000Highwire
Sep 20222300Highwire
Oct 20223311Highwire
Nov 20224500Highwire
Dec 20223400Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me